Medical Marijuana, Inc. Investment – AXIM Biotech – Featured by Reuters; Cannabis "Gum to Treat Multiple Sclerosis" Pain and Spasticity SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM® Biotechnologies,...

AXIM Featured by Reuters: Biotech Receives Cannabis Strains at “Discount for Gum to Treat Multiple Sclerosis” NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- A groundbreaking story by Reuters global news agency profiled AXIM® Biotechnologies, Inc. (OTC:AXIM) and the company’s upcoming clinical trials on the...

MJNA's Investment Company AXIM Biotech Announces Clinical Trial Launch of MedChew RX for Treatment of Pain and Spasticity in Multiple Sclerosis and Development of Pharmaceutical Cannabis Chewing Gum SAN DIEGO, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is an agricultural hemp industry innovator that sources, evaluates, invests in and acquires value-adding companies...

Photo Release -- AXIM Biotech CEO Addresses Cannabinoid Delivery Innovations at My Compassion's Cannabis Conference Chicago CHICAGO, June 23, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), a unique hemp cannabis biotechnology innovator, is proud to announce that its Chief Executive Officer, George E....

Photo Release -- AXIM Biotech Announces Hemp Innovations for Life Sciences SAN DIEGO, June 4, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical,...